Effect of Sufentanil on the Postoperative Pain

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Feb 13, 2024

Keywords

ClinConnect Summary

This clinical trial is looking to understand how effective a medication called sufentanil is in managing pain after surgery, specifically during robot-assisted nephrectomy, which is a type of kidney surgery. In this study, 48 patients will be randomly assigned to receive either sufentanil or another pain medication called remifentanil during their surgery. This means that neither the patients nor the doctors will know which medication each patient is receiving, helping to ensure fair results.

To participate, patients must be at least 18 years old and scheduled for this specific type of surgery. They should be in good health according to a specific classification system (American Society of Anesthesiologists grades 1, 2, or 3), which indicates their overall physical condition. However, patients will not be eligible if they have a history of opioid allergies, chronic pain, prior opioid use, or other specific health issues. This trial is not yet recruiting participants, so if you or someone you know is interested, it’s a good idea to stay in touch with your healthcare provider for updates.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who undergo elective robot-assisted nephrectomy surgery
• • American Society of Anesthesiologists grade 1,2,3
• • Age \> 18 years old
• Exclusion Criteria:
• • Refuse to participate to the study
• • Allergic history of opioid
• • chronic pain
• • opioid user before surgery
• • MAO inhibitor user
• • Severe respiratory insufficiency